Jedd Wolchok, MD, PhD
Disclosures: Consulting Fee-Bristol-Myers Squibb|Contracted Research-Bristol-Myers Squibb|Contracted Research-Genentech, Inc.|Contracted Research-Merck and Company, Inc.|Consulting Fee-medimmune|Contracted Research-medimmune|Consulting Fee-Adaptive Biotech|Consulting Fee-Advaxis|Consulting Fee-amgen|Consulting Fee-Apricity|Consulting Fee-Array BioPharma|Consulting Fee-Ascentage Pharma|Consulting Fee-Astellas Pharma|Consulting Fee-Bayer|Consulting Fee-Beigene|Ownership Interest-Beigene|Consulting Fee-Celgene|Consulting Fee-Chugai|Consulting Fee-Elucida|Ownership Interest-Elucida|Consulting Fee-Eli Lilly and Company|Consulting Fee-F-Star|Ownership Interest-Imvaq|Consulting Fee-Imvaq|Consulting Fee-Janssen|Consulting Fee-Kleo Pharma|Consulting Fee-Linneaus|Ownership Interest-Linneaus|Consulting Fee-Neon Therapeutics|Consulting Fee-Ono|Consulting Fee-Polynoma|Consulting Fee-Psioxus|Consulting Fee-Puretech|Consulting Fee-Recepta|Ownership Interest-Trieza|Consulting Fee-Sellas Life Sciences|Ownership Interest-Serametrix|Consulting Fee-Surface oncology|Salary-Syndax|Ownership Interest-Potenza Therapeutics|Ownership Interest-Tizona Pharmaceuticals|Ownership Interest-Adaptive Biotech|Ownership Interest-Trieza
No Bio Available.